In case Moderna does not have LNP technology that infringes on the plaintiffs’ patents, the question becomes whether some of the plaintiffs’ patents were used along the way to get to the ultimate product, says Justin Hughes, a law professor at Loyola Marymount University.
Source: Pharmaceutical Technology
COVID-19 Patent Lawsuits: Will Vaccine Producers Have to Pay the Bill?
Weather
53°moderate rain
Loyola Marymount University Newsroom
